YOUR SELEON SPECIALIST

Peter Hartung
Head of BU Consulting, QM & RA, Quality Management Expert

Tel.: 07131 2774-40
regulatoryaffairs(at)seleon.de

 

Questions on this topic?

Send us a message!

 

01.07.2019

You want to go to Canada? With an MDSAP only!

Since January 1, 2019 the MDSAP audit of your company has become mandatory for market access in Canada. Even though the other participating countries, such as the U.S., Brazil, Japan and Australia, do not have an audit obligation (yet), we cannot avoid it there. Our blog post will tell you why it is this way and why conformance with the EN ISO 13485 audit does not mean you have met all the criteria.

guidelines-mdsap-audit
guidelines-mdsap-audit
guidelines-mdsap-audit
guidelines-mdsap-audit

The pilot phase of the MDSAP has been over for a good two years now and the program is running officially. Since January 1, 2019 market access for medical devices in Canada has only been possible after a successful MDSAP. What knowledge have the seleon RA team and its customers gained during the first two years? We would like to provide you some insight:

 

MDSAP, what’s that again?

The Medical Device Single Audit Program of the International Medical Device Regulators Forum (IMDRF) – short MDSAP – regulates joint audits in accordance with the QM requirements of (currently) the U.S., Canada, Brazil, Japan and Australia. They are not performed by the authorities of the respective countries, but by selected recognized notified bodies.

 

What are the parallels and differences to the regular EN ISO 13485 audit?

First, it is essential to note that the MDSAP cannot replace your regular QM-audit according to EN ISO 13485, as Europe does not participate in the MDSAP. However, the requirements of the MDSAP audit correspond in outline to those of the EN ISO 13485, added to the specific QM-requirements of the participating countries. In other words, if you already have a QM-system in accordance to the requirements of all the MDSAP participants, you have finished a great part of the actual work. Yet, if your QM-system only covers parts of the country’s requirements or does not cover them correctly, you will have to check the processes to achieve a successful MDSAP audit. It is important to know that the audit is basically process-oriented and does not work along the chapters of the standard. The more process-oriented your QM-system is, the more advantageous it is for you and your company.

Nevertheless, this is no guarantee for a successful audit. Your MDSAP audit will be performed along the established processes using one product as an example. But what if you have only older products from a period before the implementation of MDSAP? This is not relevant for the process-oriented approach. Worst-case scenario: your older medical devices will be double-checked with the older processes and the core principles of the MDSAP. Therefore, it is worth it to compile a gap analysis, to update the documentation to the current state of art and, once again, to become familiar with the old and new processes.

 

What knowledge have the seleon regulatory affairs team and its customers gained during the first two years of the pilot phase?

The auditing is performed on one medical device. The selection criteria seem to be the biggest overlap that exists between the participating countries, the risk class and conspicuous observations regarding feedback from the market. In other words, a new product developed according to the “new process” is not likely to be chosen, but rather a so-called potentially risky long-distance runner already available in all countries. In case you only have a small product portfolio, the criteria for the selection are different.

Process-oriented auditing may reveal non-conformities that have not been revealed in previous audits according to ISO 13485 or other QM requirements. In addition, time investment is higher, and the verification of the implementation is more profound. If there are deviations, they are mostly related to the basics of the ISO 13485 and not necessarily to the specific ones of the MDSAP.

Nevertheless, it is important to ensure that the requirements of all participating countries in which the medical devices are already on the market, are implemented and not solely those of a desired target country. In Canada, for example, an MDSAP audit is mandatory, the CMDCAS process has been stopped. Deviations from the MDSAP can quickly become reportable to the respective authorities. Meaning, even if a deviation concerns only one specific country, all five participating countries will be informed. This again can quickly become painful for the audited company, as no one would like to be in the focus of a licensing or supervisory authority.

To prevent this situation, it is recommendable to follow the MDSAP guide when adapting your QM-system and to check conformance with it. The requirements and regulations of the MDSAP participating countries must be implemented and reviewed at the time of the last in-house audit prior to the MDSAP audit. That way you can kill two birds with one stone!

 

Would you like to familiarize yourself with the MDSAP?

Take a look at the guidance documents and other relevant announcements:

 

Too much paperwork all at once?

Companies such as seleon GmbH have specialized in quality management and regulatory affairs for medical devices. You will receive consulting and support during the implementation of the MDSAP audit as well as with mock audits.

 

 

Please note that all data and listings do not have the claim of completeness, are without guarantee and serve the pure information.

Every product is unique – the mandatory tasks and measures for entering the market need to be specified individually. seleon advises you on your individual questions without any obligation.

CONTACT YOUR SELEON SPECIALIST

[Inhalt: Englisch]

< BACK TO OVERVIEW

 

Further entries from the "Quality management" category

Quality Management
25.07.2019

With the MDR, there are changes to many aspects of medical devices. The UDI-system is one of them and marks a turning point in the European method of traceability, as this system aims for a standardised and simple traceability. However, until the UDI-system is fully...

Quality Management
01.07.2019

Since January 1, 2019 the MDSAP-audit of your company has become mandatory for market access in Canada. Even though the other participating countries, such as the U.S., Brazil, Japan and Australia, do not have an audit obligation (yet), we cannot avoid it there. Our...

Quality Management
14.02.2019

Nothing works without software in the planning, control and implementation of medical technology projects. Tools are needed to develop efficiently and with minimal errors. But which tools are suited best?

Regulatory Affairs

Gaining approval for medical devices is complex and quite often also confusing. We bring clarity…

 

> Regulatory Affairs

Clinical Affairs

Clinical affairs of medical devices requires numerous evidences and evaluations. What we know about it …

 

> Clinical Affairs

Development Excellence

Product development of medical devices is subject to its own rules. We bring light into the darkness …

 

> Development Excellence